In ₹ Crore except Per Share Latest Annual	COHANCE FY26	DIVISLAB FY26	SYNGENE FY26	ASTERDM FY26	Peer Average
Valuation — at last close
P/E	96.38×	92.20×	◆ 46.61×	86.32×	75.04× +28%
P/B	4.42×	14.10×	◆ 3.05×	7.36×	8.17× -46%
EV/EBITDA	40.42×	67.70×	◆ 14.70×	36.97×	39.79× +2%
Market Cap	₹17,294 Cr	₹2.36L Cr	₹14,780 Cr	₹33,678 Cr	₹94,946 Cr -82%
Growth
Revenue CAGR 3Y	◆ 19.17%	10.78%	5.40%	-26.99%	-3.60% +632%
Revenue CAGR 5Y	◆ 17.57%	8.67%	11.35%	-11.61%	2.80% +527%
Net Income CAGR 3Y	-28.53%	◆ 12.09%	-11.98%	-3.51%	-1.13% -2417%
Revenue YoY (latest Q)	-23.13%	◆ 27.80%	-8.55%	21.60%	13.62% -270%
Net Income YoY (latest Q)	-197.39%	◆ 65.50%	-52.01%	-68.70%	-18.40% -973%
Profitability
EBITDA Margin	18.82%	◆ 32.59%	24.57%	19.41%	25.52% -26%
Net Income Margin	6.62%	◆ 24.32%	8.47%	9.20%	14.00% -53%
Return on Common Equity	6.39%	◆ 16.19%	6.62%	9.70%	10.84% -41%
Return on Capital Employed	6.18%	◆ 17.80%	8.54%	9.90%	12.08% -49%
Return on Assets	3.43%	◆ 13.89%	4.57%	5.80%	8.09% -58%
Credit & Quality
Total Debt/Equity	0.04×	◆ 0.00×	0.00×	0.15×	0.05× -20%
Interest Coverage	6.44×	◆ 129.48×	9.54×	5.18×	48.07× -87%
Scale — latest FY
Revenue / Total Income	₹2,269 Cr	₹10,560 Cr	₹3,739 Cr	₹4,643 Cr	₹6,314 Cr -64%
Net Income	₹150 Cr	₹2,568 Cr	₹317 Cr	₹427 Cr	₹1,104 Cr -86%
Total Assets	₹5,730 Cr	₹20,033 Cr	₹7,055 Cr	₹8,112 Cr	₹11,733 Cr -51%
EPS	₹4.69	₹96.75	₹7.87	₹7.53	₹37.38 -87%
Book Value per Share	₹102.23	₹632.49	₹120.11	₹88.31	₹280.3 -64%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.